Amgen Inc BDR (AMGN34)

B3
Currency in BRL
56.43
-0.75(-1.31%)
Closed·

AMGN34 Financial Summary

Key Ratios

P/E Ratio26.23
Price/Book23.9
Debt / Equity924.46%
Return on Equity105.67%
Dividend Yield2.27%
EBITDA15.16B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa25,42425,97926,32328,19033,424
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa19,26519,52519,94720,39522,966
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa9,3289,15110,0989,6589,676
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,2645,8936,5526,7174,090
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa62,94861,16565,12197,15491,839
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa11,65312,18415,68718,39223,099
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa9,4096,7003,6616,2325,877
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa9,228.257,515.388,690.133,304.3813,725.88
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa10,4979,2619,7218,47111,490
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-5,401733-6,044-26,204-1,046
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-4,867-8,271-4,03721,048-9,415
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa2291,723-3603,3151,029
* In Millions of USD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 11.04%
Dividend Yield
2.27%
Industry Median 1.77%
Annualized payout
1.28
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 02, 2025
EPS / Forecast
3.20 / --
Revenue / Forecast
8.15B / --
EPS Revisions
Last 90 days

FAQ

What were Amgen Inc BDR's earnings for the latest quarter?

The Amgen Inc BDR EPS (TTM) is 11.04. Amgen Inc BDR reported sales of 8,149.00, net income of 1,730.00, and EPS of 3.20 for the latest quarter.

What was Amgen Inc BDR's net income for the latest quarter?

Amgen Inc BDR's net income for the latest quarter was 1,730.00.

How did Amgen Inc BDR's performance compare year-over-year in the latest quarter?

The company's revenue moved from 9,086.00 in the previous quarter to 8,149.00 in the latest quarter, and net income moved from 627.00 to 1,730.00 compared to the previous quarter.

What is Amgen Inc BDR's net profit margin on a TTM basis?

Amgen Inc BDR's trailing twelve months (TTM) net profit margin is 12.24%.

How does Amgen Inc BDR's debt to equity ratio compare to industry standards?

Amgen Inc BDR's total debt-to-equity ratio is 924.46%.

What is Amgen Inc BDR's return on investment on a TTM basis?

Amgen Inc BDR's trailing twelve months (TTM) return on investment (ROI) is 105.67%.

Did Amgen Inc BDR gain or lose cash last quarter?

In the latest quarter, Amgen Inc BDR's net change in cash was -3,163.00 million.

What were Amgen Inc BDR's total assets and liabilities in the latest quarter?

As of the latest quarter, Amgen Inc BDR reported total assets of 89,367.00 million and total liabilities of 23,008.00 million.

How has Amgen Inc BDR's total revenue grown this year?

Amgen Inc BDR's total revenue was 9,086.00 in the previous quarter and 8,149.00 in the latest quarter.

What is Amgen Inc BDR's gross margin on a TTM basis?

Amgen Inc BDR's trailing twelve months (TTM) gross margin is 69.07%.

What was Amgen Inc BDR's revenue per share for the latest quarter?

Amgen Inc BDR's revenue per share for the latest quarter was 120.68.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.